AUM $67.9MER 0.60%NAV $38.79Holdings 51Inception Sep 2016
Price Chart
Key Statistics
Previous Close
$38.83Day Range
$38.88$39.18
52-Week Range
$25.77$39.45
Avg Volume
2.2MDividend Yield
1.34%Expense Ratio
0.60%AUM
$67.9MShares Outstanding
950.1KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 94.88% |
| Ireland | 3.81% |
| Other | 0.77% |
| United Kingdom | 0.54% |
Fund Information
- Issuer
- First Trust
- Category
- Healthcare
- Types
- PharmaTechnology
- Inception Date
- Sep 20, 2016
- Exchange
- NASDAQ
- Description
- The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Similar ETFs
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund issued by First Trust that launched on Sep 20, 2016. It currently manages $67.9M in assets under management. The fund charges an expense ratio of 0.60%. The fund holds 51 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 53.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.60% | 2,475 | $7.2M |
| 2 | ABBV | AbbVie Inc. | 7.47% | 11,216 | $7.1M |
| 3 | MRK | Merck & Co., Inc. | 7.11% | 21,021 | $6.8M |
| 4 | JNJ | Johnson & Johnson | 7.04% | 10,477 | $6.7M |
| 5 | BMY | Bristol-Myers Squibb Company | 6.66% | 41,733 | $6.3M |
| 6 | VTRS | Viatris Inc. | 3.91% | 87,169 | $3.7M |
| 7 | BIIB | Biogen Inc. | 3.53% | 6,784 | $3.4M |
| 8 | CAH | Cardinal Health, Inc. | 3.33% | 5,678 | $3.2M |
| 9 | AMGN | Amgen Inc. | 3.23% | 3,353 | $3.1M |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | 3.22% | 2,620 | $3.1M |
| 11 | PFE | Pfizer Inc. | 3.05% | 47,068 | $2.9M |
| 12 | GILD | Gilead Sciences, Inc. | 2.96% | 8,738 | $2.8M |
| 13 | REGN | Regeneron Pharmaceuticals, Inc. | 2.82% | 1,665 | $2.7M |
| 14 | UTHR | United Therapeutics Corporation | 2.64% | 1,920 | $2.5M |
| 15 | JAZZ | Jazz Pharmaceuticals Plc | 2.60% | 3,943 | $2.5M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.49% | |
| 1W | +2.48% | |
| 1M | +1.28% | |
| 3M | +16.31% | |
| 6M | +15.60% | |
| YTD | +18.62% | |
| 1Y | +45.53% | |
| 3Y | +46.22% | |
| 5Y | +45.90% |
Moving Averages
20-Day MA
$38.52
Above 20-Day MA50-Day MA
$36.49
Above 50-Day MA200-Day MA
$33.68
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$39.45
Current Price
$39.02
52-Week Low
$25.77
$25.77$39.45
Current Yield
1.34%
Annual Dividend
$0.4212
Frequency
Quarterlyx/year
Last Ex-Date
Mar 26, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Mar 26, 2026 | $0.0573 | Mar 31, 2026 |
| Dec 12, 2025 | $0.1294 | Dec 31, 2025 |
| Sep 25, 2025 | $0.1453 | Sep 30, 2025 |
| Jun 26, 2025 | $0.0892 | Jun 30, 2025 |
| Mar 27, 2025 | $0.0992 | Mar 31, 2025 |
| Dec 13, 2024 | $0.1304 | Dec 31, 2024 |
| Sep 26, 2024 | $0.1218 | Sep 30, 2024 |
| Jun 27, 2024 | $0.1284 | Jun 28, 2024 |
| Mar 21, 2024 | $0.0676 | Mar 28, 2024 |
| Dec 22, 2023 | $0.1232 | Dec 29, 2023 |
| Sep 22, 2023 | $0.0725 | Sep 29, 2023 |
| Jun 27, 2023 | $0.1179 | Jun 30, 2023 |
| Mar 24, 2023 | $0.1001 | Mar 31, 2023 |
| Dec 23, 2022 | $0.1253 | Dec 30, 2022 |
| Dec 23, 2022 | $0.1250 | Dec 30, 2022 |
| Sep 23, 2022 | $0.0911 | Sep 30, 2022 |
| Sep 23, 2022 | $0.0910 | Sep 30, 2022 |
| Jun 24, 2022 | $0.0384 | Jun 30, 2022 |
| Jun 24, 2022 | $0.0380 | Jun 30, 2022 |
| Mar 25, 2022 | $0.0490 | Mar 31, 2022 |
Dividend Payments Over Time
Category Comparison
| Metric | FTXH | Healthcare(212 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.60% | 0.62% | 0.66% |
| AUM | $67.9M | $1.86B | $1.62B |
| Dividend Yield | 1.34% | 3.66% | 1.82% |
| Avg Volume | 2.2M | 445.6K | 519.0K |
| Holdings | 51 | 147 | 39 |
| Performance | |||
| 1-Month Return | +2.02% | -0.85% | +1.56% |
| 6-Month Return | +15.88% | +12.94% | +17.68% |
| YTD Return | +18.31% | +9.31% | +13.93% |
| 1-Year Return | +29.20% | +14.67% | +27.83% |
Compare with Another ETF
Search for an ETF to compare with FTXH:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.